Related Experiment Video
Updated: Nov 3, 2025

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Published on: April 10, 2018
Long noncoding RNA NEAT1 aggravates sorafenib-resistance in non-small cell lung cancer via regulating miRNA-335/c-Met
Lin Mu1, Hong Zhao, Yayun Yang
1Department of Pulmonary and Critical Care Medicine, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China.
Purpose:
The purpose of this study was to illustrate the role of long non-coding RNA (lncRNA) NEAT1 in inhibiting sorafenib sensitivity in non-small cell lung cancer (NSCLC) through targeting microRNA-335 (miR-335)/c-Met axis.
Methods:
Regulatory effects of NEAT1/miR-335/c-Met axis on proliferative ability of sorafenib-induced A549 and PC9 cells were assessed by cell counting kit-8 (CCK-8) and colony formation assay. Apoptosis changes influenced by nuclear paraspeckle assembly transcript 1 (NEAT1)/miR-335/c-Met axis after sorafenib treatment in lung cancer cells were examined by detecting apoptotic rate, as well as relative levels of Bcl-2 and Bax. The interaction among NEAT1/miR-335/c-Met was analyzed through dual-luciferase reporter gene assay.
Results:
Sorafenib treatment in A549 cells and PC9 cells attenuated the proliferation and induced apoptosis, which were more pronounced after silencing of NEAT1. MiR-335 was the downstream target of NEAT1, and its level was negatively regulated by NEAT1. Moreover, c-Met was the target gene of MiR -335. Rescue experiments verified the role of NEAT1/ MiR-335/c-Met regulatory loop in reducing the proliferative ability and inducing apoptosis of sorafenib-treated lung cancer cells.
Conclusions:
LncRNA NEAT1 aggravates sorafenib resistance in NSCLC through inhibiting MiR-335 to upregulate c-Met level, manifesting as attenuated proliferation and accelerated apoptosis.
Insights
Long non-coding RNA NEAT1 promotes sorafenib resistance in non-small cell lung cancer (NSCLC) by inhibiting microRNA-335 (miR-335) and upregulating c-Met. Silencing NEAT1 enhances sorafenib sensitivity, reducing proliferation and increasing apoptosis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Non-small cell lung cancer (NSCLC) exhibits resistance to targeted therapies like sorafenib.
- Long non-coding RNAs (lncRNAs) play crucial roles in cancer progression and drug resistance.
- Investigating molecular mechanisms underlying sorafenib resistance is vital for improving NSCLC treatment.
Purpose of the Study:
- To elucidate the role of lncRNA NEAT1 in modulating sorafenib sensitivity in NSCLC.
- To investigate the NEAT1/microRNA-335 (miR-335)/c-Met signaling axis in this context.
- To understand how NEAT1 influences proliferation and apoptosis in sorafenib-treated NSCLC cells.
Main Methods:
- Cell Counting Kit-8 (CCK-8) and colony formation assays assessed cell proliferation.
- Apoptosis rates and Bcl-2/Bax levels were analyzed to evaluate apoptosis.
- Dual-luciferase reporter gene assays confirmed interactions within the NEAT1/miR-335/c-Met pathway.
Main Results:
- Silencing NEAT1 significantly enhanced sorafenib-induced apoptosis and attenuated proliferation in NSCLC cells (A549 and PC9).
- NEAT1 was identified as a negative regulator of miR-335, and miR-335 directly targeted c-Met.
- Rescue experiments confirmed the NEAT1/miR-335/c-Met loop's role in mediating sorafenib resistance.
Conclusions:
- LncRNA NEAT1 exacerbates sorafenib resistance in NSCLC by inhibiting miR-335, leading to c-Met upregulation.
- This mechanism results in reduced proliferation and increased apoptosis in response to sorafenib.
- Targeting the NEAT1/miR-335/c-Met axis may represent a therapeutic strategy to overcome sorafenib resistance in NSCLC.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Types of RNA
RNA Performs Diverse...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...